Sapphire Star Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
EIP
RIM
TAM
Sapphire Star Partners's LMAT Position: Q3 2018 in Review
Sapphire Star Partners sold out of LeMaitre Vascular (LMAT) in Q3 2018, closing a stake of 12,290 shares — an estimated $412K sold.
Sapphire Star Partners first reported a position in LMAT in Q4 2017 and held it in 3 quarters. The position peaked at $450K in Q1 2018. 156 funds tracked by Wall St. Rank hold LMAT as of Q3 2018.
- Sapphire Star Partners reported no remaining LeMaitre Vascular position as of Q3 2018 after selling out during the quarter.
- Sapphire Star Partners sold 12,290 LeMaitre Vascular shares in Q3 2018, an estimated $412K.
- Sapphire Star Partners first reported a position in LeMaitre Vascular in Q4 2017 and held it in 3 quarters.
- Sapphire Star Partners's LeMaitre Vascular position peaked at $450K in Q1 2018.
- 156 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2018.
Based on Sapphire Star Partners's 13F filing for Q3 2018, filed 8 Nov 2018.